Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7281 - 7288 of 12008 results
The February 2017 Update – The Mintz Matrix
February 16, 2017| Blog| Viewpoint
CPSC Rule Process, Penalties May Change Under Buerkle
February 16, 2017| News
Software is Still Patent Eligible
February 16, 2017| Advisory| Viewpoint
Portman-Shaheen Energy Efficiency Bill Reintroduced in Senate
February 15, 2017| Blog| Viewpoint
CMS’s Draft 2018 Call Letter: Minor Updates, but Largely a Continuation of Current Policies
February 15, 2017| Blog| Viewpoint
Tax Guidance to Slow Under Trump. Even More Emphasis on Letter Rulings in Bond Transactions?
February 15, 2017| Blog| Viewpoint
Supreme Court Delays Oral Arguments Regarding Employment ‘Class Arbitration’ Waivers
February 14, 2017| Blog| Viewpoint
WEBINAR – Access, Correction, Erasure and Portability under the GDPR: How to Minimize the Burden
February 14, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|